Medicine and Dentistry
Cohort Analysis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Infection
24%
Adverse Outcome
23%
COVID-19
22%
Drug Use
20%
Venous Thromboembolism
12%
Attributable Risk
12%
Drug Therapy
12%
Nonsteroid Antiinflammatory Agent
11%
Angiotensin Receptor Antagonist
11%
Idiopathic Pulmonary Fibrosis
11%
Dermatology
11%
Messenger RNA
11%
Glucagon-Like Peptide-1 Agonist
11%
Intensive Care Unit
11%
Hazard Ratio
10%
Sodium Glucose Cotransporter 2 Inhibitor
9%
ACE Inhibitor
7%
Comorbidity
7%
Gout
7%
Tacrolimus
6%
Dipeptidyl Peptidase-4 Inhibitor
6%
Adverse Event
6%
Population
6%
Omicron Coronavirus Variant
6%
Respiratory Tract Infection
6%
Reverse Transcription Polymerase Chain Reaction
6%
Kidney Stone
5%
Thrombocytopenia
5%
Renin Angiotensin Aldosterone System
5%
Cutaneous Lymphoma
5%
Phlebothrombosis
5%
Case Fatality Rate
5%
Major Bleeding
5%
Hematologic Malignancy
5%
Anticoagulation
5%
Sensorineural Hearing Loss
5%
Cohort Effect
5%
Low Molecular Weight Heparin
5%
Cotransporter
5%
Influenza Vaccine
5%
COVID-19 Vaccine
5%
Skin Cancer
5%
Adolescence
5%
Cancer Staging
5%
Pimecrolimus
5%
Toddlers
5%
Acute Heart Infarction
5%
Troponin I
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
86%
SARS Coronavirus
41%
Infection
27%
Adverse Outcome
23%
Coronavirinae
19%
Venous Thromboembolism
13%
Gout
13%
Non-Steroidal Anti-Inflammatory Drug
12%
Case-Control Study
12%
Chronic Kidney Failure
11%
Tacrolimus
11%
Virus Infection
11%
Angiotensin Receptor Antagonist
11%
Glucagon Like Peptide 1 Receptor Agonist
11%
Messenger RNA
11%
Disease
11%
Adverse Event
10%
Prevalence
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Selective Serotonin Reuptake Inhibitor
8%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Comorbidity
7%
Statin (Protein)
7%
Non Insulin Dependent Diabetes Mellitus
6%
Respiratory Tract Infection
6%
Pharmacotherapy
6%
Glucocorticoid
6%
Low Molecular Weight Heparin
5%
Noninferiority Trial
5%
Renin
5%
Pimecrolimus
5%
Prescribing Drug
5%
Drug Distribution
5%
Restless Legs Syndrome
5%
Brain Ischemia
5%
Nephrolithiasis
5%
Febuxostat
5%
Digitalis Glycoside
5%
Minoxidil
5%
Allopurinol
5%
Drug Utilization
5%
Cotransporter
5%
Atrial Fibrillation
5%
Dicloxacillin
5%
Fibrosing Alveolitis
5%
Case Fatality Rate
5%
Antiemetic Agent
5%
Doxycycline
5%
Quetiapine
5%
Oxymetazoline
5%
Nursing and Health Professions
Cohort Analysis
23%
Severe Acute Respiratory Syndrome
22%
Adverse Outcome
17%
Infection
15%
Angiotensin Receptor Antagonist
11%
Intensive Care Unit
8%
Attributable Risk
8%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Drug Use
6%
Adverse Event
5%
Angiotensin
5%
Renin
5%
Acute Heart Infarction
5%
Epidemiology
5%
Adolescent
5%
Nonsteroid Antiinflammatory Agent
5%
BNT162b2 vaccine
5%
Troponin I
5%
